Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Opus Genetics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 38 | +2 |
| Shares | 2.70M | 106.9K | 2.53M | −57.6K (−2.2%) |
| Value | $4.13M | $163.6K | $3.32M | −$646.5K (−16.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Opus Genetics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 109,323 | $143.2K | 0.00% |
| XTX Topco Ltd | 27,892 | $36.5K | 0.00% |
| Virtu Financial LLC | 23,728 | $31.0K | 0.00% |
| Raymond James & Associates | 11,758 | $15.4K | 0.00% |
| Commonwealth Equity Services, LLC | 11,739 | $15.0K | 0.00% |
| Barclays PLC | 1,900 | $2.49K | 0.00% |
| Eastern Bank | 1,000 | $1.31K | 0.00% |
| FSA Wealth Management LLC | 5 | $7 | 0.00% |
Sold out (6)
Institutions that held Opus Genetics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Rice Hall James & Associates, LLC | 223,589 | $342.1K |
| Jane Street Group, LLC | 42,375 | $64.8K |
| Simplex Trading, LLC | 1,335 | $2.00K |
| Proequities, Inc. | 727 | $1.11K |
| Group One Trading, L.P. | 76 | $116 |
| Rhumbline Advisers | 26 | $39 |
Not filed for Q3 2024 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 106,935 | $163.6K |